Skip to main content
Daily Report

Daily Cosmetic Research Analysis

05/03/2026
3 papers selected
9 analyzed

Analyzed 9 papers and selected 3 impactful papers.

Summary

Analyzed 9 papers and selected 3 impactful articles.

Selected Articles

1. Exploring the efficacy evaluation model for androgenic alopecia using hair organoids: Transcending conventional hair research.

73Level VBasic research
Journal of dermatological science · 2026PMID: 42067458

An ES cell–derived hair-bearing organoid model reproduced DHT-induced androgenic alopecia phenotypes and quantified rescue by minoxidil and a certified cosmetic extract. The system integrates molecular, cellular, and ex vivo readouts, offering a robust preclinical platform for screening therapeutic and cosmetic anti-AGA agents.

Impact: Introduces a functional, hair-bearing organoid model that directly addresses the lack of scalable, human-relevant AGA efficacy platforms, bridging cosmetic and therapeutic development.

Clinical Implications: Enables earlier, human-relevant screening of anti-alopecia candidates, potentially reducing animal use and accelerating translation; supports biomarker-driven dose finding before clinical trials.

Key Findings

  • Hair-bearing organoids formed over ~100 days from ES cells and exhibited quantifiable pigmented hairs.
  • DHT at 1 µM reduced pigmented hair numbers and downregulated hair growth markers (e.g., SOX2, PCNA).
  • Co-treatment with 200 µg/mL SOYACT or minoxidil restored hair counts and biomarker expression.
  • Efficacy assessments were supported by MTT, RT-PCR, immunohistochemistry, and ex vivo organ culture.

Methodological Strengths

  • Human-relevant organoid model integrating cellular, molecular, and ex vivo endpoints
  • Controlled induction of AGA-like state with DHT enabling causal testing of interventions

Limitations

  • Preclinical in vitro/ex vivo work without in vivo or clinical validation
  • Single DHT dose and limited reporting of sample sizes may constrain generalizability

Future Directions: Validate with human iPSC-derived follicles and patient-derived cells, expand dose–response and longitudinal readouts, and align markers with clinical endpoints for trial translation.

BACKGROUND: The development of effective evaluation tools for anti-hair loss therapies is critical due to limitations in existing experimental systems. Hairy 3D skin models and hairy skin explants are not yet commercially viable, necessitating alternative approaches for assessing androgenic alopecia (AGA). OBJECTIVE: This study aimed to develop a hair-bearing organoid model derived from embryonic stem (ES) cells to evaluate the efficacy of compounds against AGA. METHODS: Organoids were cultured from ES cells for approximately 100 days until hair follicle formation began. AGA conditions were induced by treating organoids with dihydrotestosterone (DHT). The recovery effects were assessed using minoxidil (MXD) and soybean embryo extract (SOYACT), a cosmetic ingredient certified for mitigating hair loss. The efficacy of SOYACT was validated through MTT assays, RT-PCR, and ex vivo organ culture. Hair numbers were quantified, and biomarkers related to hair growth, including SOX2, PCNA were analyzed via immunohistochemistry. RESULTS: DHT treatment at 1 µM significantly reduced pigmented hair numbers and decreased expression of hair growth-associated biomarkers. Conversely, co-treatment with 200 μg/mL SOYACT or MXD mitigated these effects, restoring hair follicle numbers and biomarker expression levels. These findings demonstrated the successful induction of AGA conditions in hair-bearing organoids and their response to anti-hair loss ingredients. CONCLUSION: This study highlights the utility of hair-bearing organoids as a novel experimental model for evaluating AGA therapies. The organoid model addresses limitations in traditional in vitro systems, providing a robust platform for efficacy testing of therapeutic and cosmetic interventions targeting androgenic alopecia.

2. Enhanced biodistribution and efficacy of nicomenthyl encapsulated in emulsions stabilized by methacrylated hyaluronic acid for the prevention and treatment of skin photoaging.

64.5Level VBasic research
Carbohydrate polymers · 2026PMID: 42067346

Methacrylated hyaluronic acid–stabilized emulsions delivered nicomenthyl beyond the stratum corneum to basal layers, enhancing ECM restoration and dampening UVB-induced IL-6/IL-8. Compared with free nicomenthyl, the emulsion accelerated scratch closure and upregulated COL I/III and elastin, supporting a UV-protective, anti-aging cosmetic strategy.

Impact: Demonstrates a polysaccharide-based delivery strategy that overcomes stratum corneum retention and potentiates a widely used cosmetic active, with multimodal in vitro and ex vivo validation.

Clinical Implications: Suggests formulation routes to increase dermal bioavailability of niacinamide prodrugs, potentially improving anti-photoaging efficacy and barrier support in topical products.

Key Findings

  • HA-MA–stabilized 265 nm emulsions with 5 wt% nicomenthyl increased COL I/III and elastin in HDFs by 3.22×, 2.84×, and 1.98× versus baseline.
  • Scratch assays showed >90% closure at 24 h with EM-NM, outperforming nicomenthyl alone.
  • EM-NM reached the stratum basale within 24 h and reduced UVB-induced IL-6/IL-8 while restoring COL I/III in photoaged skin models.
  • Epidermal SPTLC2 rose 1.87× and dermal ELN 1.69×, indicating improved barrier lipid synthesis and elastogenesis.

Methodological Strengths

  • Integrated biodistribution with functional (scratch), inflammatory (IL-6/IL-8), and ECM biomarker readouts
  • Direct comparison against free nicomenthyl to demonstrate delivery advantage

Limitations

  • Findings are limited to in vitro and ex vivo models; no human clinical data
  • Short-term assessments (24 h) and safety/irritation profiles not fully characterized

Future Directions: Assess long-term skin retention, clinical tolerability, and efficacy; explore dose optimization and combination with UV filters in controlled human studies.

Nicomenthyl (NM), prodrug of niacinamide (vitamin B3), is widely used in skin applications for their biological benefits, but remain mainly in the stratum corneum (SC). Bioactive methacrylate-functionalized hyaluronic acid (HA-MA) (44.5 KDa; degree of substitution: 80-100%), used to stabilize Oil-in-Water emulsions (EM) as new application for polysaccharide, represent an effective strategy to trespass SC. Here, 265 nm stable EMs containing 5 wt% NM (EM-NM) resulted in 3.22, 2.84 and 1.98 fold-increase of COL I/III and Elastin expression, respectively, compared to basal levels of HDF cells. After 24 h, >90% of HaCat/HDF scratched area was covered with EM-NM, significantly higher than NM alone. UVB protection and anti-inflammatory activity of EM-NM were confirmed by recovering IL-6 basal level for UV-irradiated HaCat/HDF cell. While EM-NM reached stratum basale after 24 h-biodistribution studies, it reduced UVB-induced IL-6/IL-8 expression and restored COL I/III expression in photoaged skin models to healthy skin phenotype. While SPTLC2 expression was increased by 1.87-fold in the epidermis, ELN expression was increased by 1.69-fold in the dermis. Altogether, EM-NM proved to enhance NM biological activity and promote skin barrier function of the epidermis and increase elastin production in the dermis, highlighting its potential as a UV-protective and anti-aging cosmetic ingredient.

3. Experimental Investigation of the Crystallization and Thermal Behavior of Animal Fat Mixtures Using a Multi-Technique Approach.

62.5Level VBasic research
Molecular nutrition & food research · 2026PMID: 42068041

Using DSC, in situ turbidity, and synchrotron SAXS/WAXS under static and sheared conditions, the study shows that TAG composition dictates crystallization pathways of chicken and beef fats. All three major polymorphs and transitions were observed, with shear promoting more stable polymorphs—insights relevant to cosmetic formulation texture and stability.

Impact: Provides mechanistic, structure-resolved understanding of fat polymorphism under processing conditions, informing how cosmetic formulations can be engineered for desired sensory and stability profiles.

Clinical Implications: Indirect clinical relevance: guides selection and processing of lipid excipients in topical formulations to optimize stability, spreadability, and sensory attributes.

Key Findings

  • Crystallization behavior of chicken and beef fats correlates closely with triacylglycerol composition.
  • Synchrotron SAXS/WAXS resolved all three main polymorphs and their transitions in both fat types.
  • Shear conditions promoted crystallization of more stable polymorphs compared with static conditions.
  • Thermal (DSC) and structural (SAXS/WAXS) data jointly mapped polymorphic pathways relevant to formulation.

Methodological Strengths

  • Multi-technique, in situ structural characterization including synchrotron SAXS/WAXS
  • Comparison of static versus sheared crystallization capturing process-relevant effects

Limitations

  • Limited to animal fats (chicken, beef); generalizability to plant oils/waxes used in cosmetics not assessed
  • Does not directly link polymorph profiles to end-product sensory metrics or long-term stability

Future Directions: Extend to plant-based lipids and complex emulsions/balms, quantify links between polymorphs and sensory/stability outcomes, and model shear/temperature histories relevant to manufacturing.

Fats are essential ingredients widely used in the food industry, as well as in cosmetic and pharmaceutical formulations. Solid fats are complex multicomponent systems primarily composed of triacylglycerols (TAGs), which determine the types and properties of the crystalline structures formed. TAGs crystallize in different polymorphs and stacking configurations, with distinct thermal and mechanical properties that influence the macroscopic structure and sensory profile of fat-based products. In this study, a comprehensive multi-technique analysis of animal-derived fats, specifically chicken and beef fats, was conducted. Chemical characterization was performed and solid fat content (SFC) was determined. Thermal behaviour was investigated using differential scanning calorimetry (DSC), whereas crystallization experiments were conducted using in situ turbidity measurements and synchrotron small-angle and wide-angle x-ray scattering (SAXS/WAXS) for structural characterization. Three different synchrotron experimental setups were used for crystallization experiments, including static and sheared conditions. The results demonstrate that the crystallization behaviour of beef and chicken fat samples closely correlate with their TAGs composition. Synchrotron x-ray scattering provided structural insights, highlighting how the polymorphic behaviour is influenced by fat origin and crystallization conditions. For both animal fat types, all three main polymorphs and possible transitions were detected. Moreover, the presence of shear promoted crystallization of stable polymorphs.